We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Commercial International Bank Egypt CIB | LSE:CBKD | London | Depository Receipt |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.386 | 1.38 | 1.386 | 0 | 00:00:00 |
Condensed Consolidated Interim Statement of Financial Position as at September 30, 2024
|
||||||||
|
|
Notes |
Sep. 30, 2024 |
|
Dec. 31, 2023 |
|||
|
|
|
|
|
||||
|
Assets |
|
|
|
|
|||
|
Cash and balances at the central bank |
9 |
94,568,773 |
|
71,887,821 |
|||
|
Due from banks |
10 |
305,235,726 |
|
231,085,244 |
|||
|
Loans and advances to banks, net |
12 |
3,323,215 |
|
822,448 |
|||
|
Loans and advances to customers, net |
13 |
304,043,669 |
|
234,985,936 |
|||
|
Derivative financial instruments |
|
1,769,619 |
|
1,105,148 |
|||
|
Financial investments |
|
|
|
|
|||
|
- Financial Assets at Fair Value through P&L |
14 |
2,066,889 |
|
- |
|||
|
- Financial Assets at Fair Value through OCI |
14 |
223,821,557 |
|
233,125,234 |
|||
|
- Financial Assets at Amortized cost |
14 |
145,437,207 |
|
38,341,019 |
|||
|
- Investments in associates |
15 |
107,446 |
|
115,979 |
|||
|
Non current assets held for sale |
30.1 |
- |
|
161 |
|||
|
Other assets |
16 |
34,331,134 |
|
18,972,786 |
|||
|
Deferred tax assets |
|
2,135,720 |
|
1,685,231 |
|||
|
Property and equipment |
17 |
3,117,062 |
|
2,739,092 |
|||
|
Total assets |
|
1,119,958,017 |
|
834,866,099 |
|||
|
Liabilities and equity |
|
|
|
|
|||
|
Liabilities |
|
|
|
|
|||
|
Due to banks |
18 |
3,799,980 |
|
12,458,003 |
|||
|
Due to customers |
19 |
900,966,962 |
|
677,237,479 |
|||
|
Non current liabilities held for sale |
30.2 |
1,327 |
|
873 |
|||
|
Derivative financial instruments |
|
138,896 |
|
140,934 |
|||
|
Current income tax liabilities |
|
14,269,506 |
|
9,395,534 |
|||
|
Other liabilities |
20 |
21,760,126 |
|
18,339,465 |
|||
|
Issued debt instruments |
21 |
4,811,742 |
|
3,073,349 |
|||
|
Other loans |
|
20,324,693 |
|
12,483,907 |
|||
|
Other provisions |
22 |
15,478,489 |
|
11,095,089 |
|||
|
Total liabilities |
|
981,551,721 |
|
744,224,633 |
|||
|
Equity |
|
|
|
|
|||
|
Issued and paid up capital |
|
30,431,580 |
|
30,195,010 |
|||
|
Reserves |
|
62,260,417 |
|
28,807,042 |
|||
|
Reserve for employee stock ownership plan (ESOP) |
|
1,667,230 |
|
1,486,010 |
|||
|
Retained earnings * |
|
43,924,408 |
|
29,993,331 |
|||
|
Total equity and net profit for the period / year |
|
138,283,635 |
|
90,481,393 |
|||
|
Non Controlling Interest |
|
122,661 |
|
160,073 |
|||
|
Total minority interest, equity and net profit for the period / year |
138,406,296 |
|
90,641,466 |
||||
|
Total liabilities and equity |
|
1,119,958,017 |
|
834,866,099 |
Condensed Consolidated Interim Income Statement for the period ended September 30, 2024 |
||||||
|
|
|
Last 9 Months |
|
|
Last 9 Months |
|
Notes |
|
Sep. 30, 2024 |
|
|
Sep. 30, 2023 |
|
|
|
|
|
|
|
Interest and similar income |
|
|
130,999,623 |
|
|
73,006,422 |
Interest and similar expense |
|
|
(65,316,717) |
|
|
(35,275,583) |
Net interest income |
|
|
65,682,906 |
|
|
37,730,839 |
|
|
|
|
|
|
|
Fee and commission income |
|
|
9,274,284 |
|
|
6,543,585 |
Fee and commission expense |
|
|
(4,049,111) |
|
|
(2,589,680) |
Net fee and commission income |
|
|
5,225,173 |
|
|
3,953,905 |
|
|
|
|
|
|
|
Dividend income |
|
|
70,934 |
|
|
83,653 |
Net trading income |
6 |
|
18,194,491 |
|
|
3,165,144 |
Profits (Losses) on financial investments |
14.1 |
|
377,992 |
|
|
165,478 |
Administrative expenses |
|
|
(9,180,646) |
|
|
(6,501,663) |
Other operating income (expenses) |
7 |
|
(17,995,808) |
|
|
(5,679,447) |
Goodwill amortization |
|
|
- |
|
|
(30,943) |
Intangible assets amortization |
|
|
- |
|
|
(24,188) |
Impairment release (charges) for credit losses |
|
|
(3,745,003) |
|
|
(1,216,770) |
Bank's share in the profits / losses of associates |
|
|
(8,533) |
|
|
(39,486) |
Profit before income tax |
|
|
58,621,506 |
|
|
31,606,522 |
|
|
|
|
|
|
|
Income tax expense |
29 |
|
(17,207,903) |
|
|
(9,540,412) |
Deferred tax assets (Liabilities) |
29 |
|
934,295 |
|
|
392,680 |
Net profit from continued operations |
|
|
42,347,898 |
|
|
22,458,790 |
|
|
|
|
|
|
|
Discontinued Operations |
|
|
|
|
|
|
Net profit (loss) from discontinued operations |
30.3 |
|
- |
|
|
(49,699) |
Net profit for the period |
|
|
42,347,898 |
|
|
22,409,091 |
|
|
|
|
|
|
|
Non Controlling Interest |
|
|
(45) |
|
|
3,328 |
Bank's shareholders |
|
|
42,347,943 |
|
|
22,405,763 |
|
|
|
|
|
|
|
Earnings per share |
8 |
|
|
|
|
|
Basic |
|
|
12.42 |
|
|
6.41 |
Diluted |
|
|
12.26 |
|
|
6.33 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Islam Zekry |
|
|
|
Hisham Ezz Al-Arab |
||
Group CFO |
|
|
|
Chairman |
|
|
|
|
|
Condensed Consolidated Interim statement of Comprehensive Income for the period ended September 30, 2024 |
||||
|
|
Last 9 Months |
|
Last 9 Months |
|
|
Sep. 30, 2024 |
|
Sep. 30, 2023 |
|
|
|
|
|
Net profit for the period |
|
42,347,898 |
|
22,409,091 |
|
|
|
|
|
Transferred to RE from financial assets at fair value through comprehensive income |
|
(370,224) |
|
(95,308) |
Change in fair value of Financial investments measured at fair value through comprehensive income after tax |
|
8,272,930 |
|
(9,629,911) |
Cumulative foreign currencies translation differences |
|
883,684 |
|
193,162 |
Effect of ECL on fair value of debt instruments measured at fair value through comprehensive income |
|
623,199 |
|
201,185 |
Total comprehensive income for the period |
|
51,757,487 |
|
13,078,219 |
|
|
|
|
|
|
|
|
|
|
As follows: |
|
|
|
|
Bank's shareholders |
|
51,757,532 |
|
13,074,891 |
Non Controlling Interest |
|
(45) |
|
3,328 |
Total comprehensive income for the period |
|
51,757,487 |
|
13,078,219 |
|
|
|
|
|
Condensed Consolidated Interim Cash flows for the period ended September 30, 2024 |
||||
|
|
|
|
|
|
Notes |
Sep. 30, 2024 |
|
Sep. 30, 2023 |
|
|
|
|
|
Cash flow from operating activities |
|
|
|
|
Profit before income tax from continued operations |
|
58,621,506 |
|
31,606,522 |
Profit (loss) from discontinued operations |
|
- |
|
(49,699) |
Adjustments to reconcile profits to net cash provided by operating activities |
|
|
|
|
Fixed assets depreciation |
17 |
763,079 |
|
655,051 |
Impairment Release/charge for credit losses (Loans and advances to customers and banks) |
|
4,224,251 |
|
1,050,980 |
Other provisions Release/charge |
22 |
430,005 |
|
2,350,253 |
Impairment Release/charge for credit losses (due from banks) |
|
829 |
|
(47,249) |
Impairment Release/charge for credit losses (financial investments) |
|
(480,077) |
|
213,039 |
Impairment Release/charge for other assets |
|
(11,956) |
|
14,347 |
Exchange revaluation differences for financial assets at fair value through OCI and AC |
|
(18,536,183) |
|
(5,409,592) |
Goodwill amortization |
|
- |
|
30,943 |
Intangible assets amortization |
|
- |
|
24,188 |
Revaluation differences Impairment charge for Financial Assets at Fair value through OCI |
|
1,193,810 |
|
- |
Revaluation differences Impairment charge for Financial Assets at Amortized cost |
|
107,207 |
|
- |
Revaluation differences Impairment charge for due from banks |
|
1,308 |
|
- |
Utilization of other provisions |
22 |
(9,196) |
|
(1,608) |
Exchange Revaluation differences of other provisions |
22 |
3,962,591 |
|
1,096,665 |
Profits/losses from selling property and equipment |
7 |
(2,254) |
|
(194) |
Profits/losses from selling financial investments at fair value through OCI |
14.1 |
(377,992) |
|
(149,012) |
Losses (Profits) from selling investments in associates |
|
- |
|
(7,466) |
Impairment (Released) charges of investments in associates |
|
- |
|
(9,000) |
Share based payments |
|
804,345 |
|
608,250 |
Bank's share in the profits / losses of associates |
|
8,533 |
|
39,486 |
Operating profits before changes in operating assets and liabilities |
|
50,699,806 |
|
32,015,904 |
|
|
|
|
|
Net decrease / increase in assets and liabilities |
|
|
|
|
Due from banks |
|
(14,547,420) |
|
9,859,636 |
Financial assets at fair value through P&L |
|
(2,066,889) |
|
- |
Derivative financial instruments |
|
(225,875) |
|
172,635 |
Loans and advances to banks and customers |
12 - 13 |
(75,774,541) |
|
(27,548,758) |
Other assets |
|
(14,094,581) |
|
(2,506,019) |
Non current assets held for sale |
|
- |
|
(214) |
Due to banks |
18 |
(8,658,023) |
|
15,526,008 |
Due to customers |
19 |
223,729,483 |
|
136,052,663 |
Current income tax obligations paid |
|
(2,938,397) |
|
(2,546,958) |
Non current liabilities held for sale |
|
1,327 |
|
933 |
Other liabilities |
|
(5,488,554) |
|
(3,890,097) |
Net cash generated from (used in) operating activities |
|
150,636,336 |
|
157,135,733 |
|
|
|
|
|
Cash flow from investing activities |
|
|
|
|
Proceeds from sale of investments in associates |
|
11,956 |
|
2,119 |
Payments for purchases of property, equipment and branches construction |
|
(2,401,070) |
|
(1,177,450) |
Proceeds from selling property and equipment |
|
2,254 |
|
194 |
Proceeds from redemption of financial assets at amortized cost |
|
1,226,638 |
|
5,278,030 |
Payments for purchases of financial assets at amortized cost |
|
(106,105,142) |
|
(9,334,085) |
Payments for purchases of financial assets at fair value through OCI |
|
(22,138,419) |
|
(64,860,157) |
Proceeds from selling financial assets at fair value through OCI |
|
55,475,567 |
|
75,128,566 |
Payment for investment in subsidiaries |
|
- |
|
(1,008,761) |
Net cash generated from (used in) investing activities |
|
(73,928,216) |
|
4,028,456 |
|
||||
Condensed Consolidated Interim Cash flows for the period ended September 30, 2024 (Cont.) |
||||
|
|
|
|
|
|
|
Sep. 30, 2024 |
|
Sep. 30, 2023 |
|
|
|
|
|
Cash flow from financing activities |
|
|
|
|
Other loans |
|
7,840,786 |
|
2,408,739 |
Dividends paid |
|
(5,116,159) |
|
(3,594,747) |
Issued debt instruments |
|
1,738,393 |
|
615,227 |
Capital increase |
|
236,570 |
|
369,876 |
Net cash generated from (used in) financing activities |
|
4,699,590 |
|
(200,905) |
|
|
|
|
|
Net (decrease) increase in cash and cash equivalent during the period |
|
81,407,710 |
|
160,963,284 |
Beginning balance of cash and cash equivalent |
|
234,317,913 |
|
92,969,526 |
Cash and cash equivalent at the end of the period |
|
315,725,623 |
|
253,932,810 |
|
|
|
|
|
Cash and cash equivalent comprise: |
|
|
|
|
Cash and balances at the central bank |
9 |
94,568,773 |
|
59,950,223 |
Due from banks |
|
305,240,021 |
|
276,845,003 |
Treasury bills and other governmental notes |
11 |
82,174,775 |
|
71,507,826 |
Obligatory reserve balance with CBE |
|
(76,360,420) |
|
(52,963,236) |
Due from banks with maturity more than three months |
|
(19,125,420) |
|
(30,994,611) |
Treasury bills and other governmental notes with maturity more than three months |
|
(70,772,106) |
|
(70,412,395) |
Total cash and cash equivalent |
|
315,725,623 |
|
253,932,810 |
Condensed Consolidated Interim statement of changes in shareholders' equity |
|
|||||||||||||
Sep. 30, 2023 |
Issued and paid up capital |
Legal reserve |
General reserve |
General risk reserve |
Reserve for transactions under common control |
Capital reserve |
Reserve for financial assets at fair value through OCI |
Banking risks reserve |
Retained earnings |
Reserve for employee stock ownership plan |
Cumulative foreign currencies translation differences |
Total Shareholders Equity |
Non Controlling Interest |
Total |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Beginning balance |
29,825,134 |
3,963,946 |
27,096,858 |
1,550,906 |
8,183 |
18,947 |
(13,188,818) |
11,981 |
16,393,841 |
1,895,435 |
181,324 |
67,757,737 |
580,431 |
68,338,168 |
Capital increase |
369,876 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
369,876 |
- |
369,876 |
Reserve for transactions under common control |
- |
- |
- |
- |
(679,155) |
- |
- |
- |
- |
- |
- |
(679,155) |
- |
(679,155) |
Transferred to reserves |
- |
806,408 |
12,743,849 |
- |
- |
2,208 |
- |
- |
(12,388,223) |
(1,164,242) |
- |
- |
- |
- |
Net profit for the period |
- |
- |
- |
- |
- |
- |
- |
- |
22,405,763 |
- |
- |
22,405,763 |
3,328 |
22,409,091 |
Dividends paid |
- |
- |
- |
- |
- |
- |
- |
- |
(3,738,888) |
- |
- |
(3,738,888) |
(17,108) |
(3,755,996) |
Change in non controlling interest from acquisition of subsidiaries |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
(536,867) |
(536,867) |
Transferred to RE from financial assets at fair value through OCI |
- |
- |
- |
- |
- |
- |
(95,308) |
- |
95,308 |
- |
- |
- |
- |
- |
Net unrealized gain/(loss) on financial assets at fair value through OCI after tax |
- |
- |
- |
- |
- |
- |
(9,629,911) |
- |
- |
- |
- |
(9,629,911) |
- |
(9,629,911) |
Transferred (from) to banking risk reserve |
- |
- |
- |
- |
- |
- |
- |
3,249 |
(3,249) |
- |
- |
- |
- |
- |
Effect of ECL in fair value of debt instruments measured at fair value through OCI |
- |
- |
- |
- |
- |
- |
201,185 |
- |
- |
- |
- |
201,185 |
- |
201,185 |
Cost of employees stock ownership plan (ESOP) |
- |
- |
- |
- |
- |
- |
- |
- |
- |
608,250 |
- |
608,250 |
- |
608,250 |
Cumulative foreign currencies translation differences |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
11,838 |
11,838 |
99,192 |
111,030 |
Ending balance |
30,195,010 |
4,770,354 |
39,840,707 |
1,550,906 |
(670,972) |
21,155 |
(22,712,852) |
15,230 |
22,764,552 |
1,339,443 |
193,162 |
77,306,695 |
128,976 |
77,435,671 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sep. 30, 2024 |
Issued and paid up capital |
Legal reserve |
General reserve |
General risk reserve |
Reserve for transactions under common control |
Capital reserve |
Reserve for financial assets at fair value through OCI |
Banking risks reserve |
Retained earnings |
Reserve for employee stock ownership plan |
Cumulative foreign currencies translation differences |
Total Shareholders Equity |
Non Controlling Interest |
Total |
Beginning balance |
30,195,010 |
4,770,354 |
39,840,707 |
1,550,906 |
(670,972) |
21,155 |
(16,868,691) |
15,230 |
29,993,331 |
1,486,010 |
148,353 |
90,481,393 |
160,073 |
90,641,466 |
Capital increase |
236,570 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
236,570 |
- |
236,570 |
Transferred to reserves |
- |
1,438,320 |
22,582,085 |
- |
- |
1,663 |
- |
- |
(23,398,943) |
(623,125) |
- |
- |
- |
- |
Dividends paid |
- |
- |
- |
- |
- |
- |
- |
- |
(5,366,429) |
- |
- |
(5,366,429) |
(37,367) |
(5,403,796) |
Net profit for the period |
- |
- |
- |
- |
- |
- |
- |
- |
42,347,943 |
- |
- |
42,347,943 |
(45) |
42,347,898 |
Transferred to RE from financial assets at fair value through OCI |
- |
- |
- |
- |
- |
- |
(370,224) |
- |
370,224 |
- |
- |
- |
- |
- |
Change in non controlling interest from acquisition of subsidiaries |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Transferred from RE to banking risk reserve |
- |
- |
- |
- |
- |
- |
- |
19,024 |
(19,024) |
- |
- |
- |
- |
- |
Net unrealised gain/(loss) on financial assets at fair value through OCI after tax |
- |
- |
- |
- |
- |
- |
8,272,930 |
- |
- |
- |
- |
8,272,930 |
- |
8,272,930 |
Transferred (from) to banking risk reserve |
- |
- |
- |
- |
- |
- |
- |
2,694 |
(2,694) |
- |
- |
- |
- |
- |
Effect of ECL in fair value of debt instruments measured at fair value through OCI |
- |
- |
- |
- |
- |
- |
623,199 |
- |
- |
- |
- |
623,199 |
- |
623,199 |
Cost of employees stock ownership plan (ESOP) |
- |
- |
- |
- |
- |
- |
- |
- |
- |
804,345 |
- |
804,345 |
- |
804,345 |
Cumulative foreign currencies translation differences |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
883,684 |
883,684 |
- |
883,684 |
Ending balance |
30,431,580 |
6,208,674 |
62,422,792 |
1,550,906 |
(670,972) |
22,818 |
(8,342,786) |
36,948 |
43,924,408 |
1,667,230 |
1,032,037 |
138,283,635 |
122,661 |
138,406,296 |
1 Year Commercial International... Chart |
1 Month Commercial International... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions